FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1894367943> ?p ?o ?g. }

• W1894367943 endingPage "314" @default.
• W1894367943 startingPage "306" @default.
• W1894367943 abstract "IL-2 is a potent immunostimulant and has been tested for clinical use, including in immunotherapy for cancers and HIV infection. Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo. Coinjection of the anti-IL-2 mAb with a plasmid carrying murine IL-2 cDNA significantly increased the serum IL-2 levels and induced a substantial increase in the division of CD8+ T and NK1.1(high) cells in vivo. Injection of the mAb premixed with recombinant murine IL-2 showed the same enhanced effect. A 5-day treatment with the anti-IL-2 mAb alone gradually increased the CD44(high)CD8+ population, and the increased population was maintained for >300 days, suggesting that the mAb can gradually maintain and potentially enhance the bioactivity of endogenous IL-2 for extended periods. Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone. These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications." @default.
• W1894367943 created "2016-06-24" @default.
• W1894367943 creator A5056051274 @default.
• W1894367943 creator A5063407770 @default.
• W1894367943 creator A5067646756 @default.
• W1894367943 creator A5068093589 @default.
• W1894367943 creator A5069272787 @default.
• W1894367943 creator A5088800991 @default.
• W1894367943 date "2006-07-01" @default.
• W1894367943 modified "2023-09-23" @default.
• W1894367943 title "IL-2 In Vivo Activities and Antitumor Efficacy Enhanced by an Anti-IL-2 mAb" @default.
• W1894367943 cites W115589848 @default.
• W1894367943 cites W1487804095 @default.
• W1894367943 cites W1501496773 @default.
• W1894367943 cites W1504879144 @default.
• W1894367943 cites W1517017118 @default.
• W1894367943 cites W1568984819 @default.
• W1894367943 cites W1577603732 @default.
• W1894367943 cites W1643040145 @default.
• W1894367943 cites W1827667265 @default.
• W1894367943 cites W1876974675 @default.
• W1894367943 cites W1971179964 @default.
• W1894367943 cites W1972924063 @default.
• W1894367943 cites W1977404966 @default.
• W1894367943 cites W1982051091 @default.
• W1894367943 cites W1993898431 @default.
• W1894367943 cites W1997196319 @default.
• W1894367943 cites W2000208875 @default.
• W1894367943 cites W2002540493 @default.
• W1894367943 cites W2006027051 @default.
• W1894367943 cites W2006409600 @default.
• W1894367943 cites W2006981670 @default.
• W1894367943 cites W2026991428 @default.
• W1894367943 cites W2031013062 @default.
• W1894367943 cites W2031464151 @default.
• W1894367943 cites W2055522356 @default.
• W1894367943 cites W2056339396 @default.
• W1894367943 cites W2063068982 @default.
• W1894367943 cites W2068639447 @default.
• W1894367943 cites W2068869473 @default.
• W1894367943 cites W2070607735 @default.
• W1894367943 cites W2072689813 @default.
• W1894367943 cites W2074068392 @default.
• W1894367943 cites W2079721061 @default.
• W1894367943 cites W2079767086 @default.
• W1894367943 cites W2095936476 @default.
• W1894367943 cites W2099784945 @default.
• W1894367943 cites W2126480955 @default.
• W1894367943 cites W2127756533 @default.
• W1894367943 cites W2143579429 @default.
• W1894367943 cites W2157822148 @default.
• W1894367943 cites W2160613172 @default.
• W1894367943 cites W2164701887 @default.
• W1894367943 cites W2313861582 @default.
• W1894367943 cites W2321760582 @default.
• W1894367943 cites W2416896529 @default.
• W1894367943 doi "https://doi.org/10.4049/jimmunol.177.1.306" @default.
• W1894367943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16785526" @default.
• W1894367943 hasPublicationYear "2006" @default.
• W1894367943 type Work @default.
• W1894367943 sameAs 1894367943 @default.
• W1894367943 citedByCount "62" @default.
• W1894367943 countsByYear W18943679432012 @default.
• W1894367943 countsByYear W18943679432013 @default.
• W1894367943 countsByYear W18943679432014 @default.
• W1894367943 countsByYear W18943679432015 @default.
• W1894367943 countsByYear W18943679432016 @default.
• W1894367943 countsByYear W18943679432017 @default.
• W1894367943 countsByYear W18943679432018 @default.
• W1894367943 countsByYear W18943679432019 @default.
• W1894367943 countsByYear W18943679432020 @default.
• W1894367943 countsByYear W18943679432021 @default.
• W1894367943 countsByYear W18943679432022 @default.
• W1894367943 countsByYear W18943679432023 @default.
• W1894367943 crossrefType "journal-article" @default.
• W1894367943 hasAuthorship W1894367943A5056051274 @default.
• W1894367943 hasAuthorship W1894367943A5063407770 @default.
• W1894367943 hasAuthorship W1894367943A5067646756 @default.
• W1894367943 hasAuthorship W1894367943A5068093589 @default.
• W1894367943 hasAuthorship W1894367943A5069272787 @default.
• W1894367943 hasAuthorship W1894367943A5088800991 @default.
• W1894367943 hasBestOaLocation W18943679431 @default.
• W1894367943 hasConcept C150903083 @default.
• W1894367943 hasConcept C153911025 @default.
• W1894367943 hasConcept C159654299 @default.
• W1894367943 hasConcept C202751555 @default.
• W1894367943 hasConcept C203014093 @default.
• W1894367943 hasConcept C207001950 @default.
• W1894367943 hasConcept C2777701055 @default.
• W1894367943 hasConcept C2780932548 @default.
• W1894367943 hasConcept C2908647359 @default.
• W1894367943 hasConcept C542903549 @default.
• W1894367943 hasConcept C55493867 @default.
• W1894367943 hasConcept C71924100 @default.
• W1894367943 hasConcept C86803240 @default.
• W1894367943 hasConcept C8891405 @default.
• W1894367943 hasConcept C98274493 @default.
• W1894367943 hasConcept C99454951 @default.

• next